FY2025 Earnings Estimate for UNH Issued By Cantor Fitzgerald

UnitedHealth Group Incorporated (NYSE:UNH) – Investment analysts at Cantor Fitzgerald increased their FY2025 earnings per share (EPS) estimates for shares of UnitedHealth Group in a research report issued to clients and investors on Wednesday, October 29th. Cantor Fitzgerald analyst S. James now expects that the healthcare conglomerate will earn $16.30 per share for the year, up from their prior estimate of $16.01. Cantor Fitzgerald currently has a “Overweight” rating and a $440.00 price objective on the stock. The consensus estimate for UnitedHealth Group’s current full-year earnings is $29.54 per share. Cantor Fitzgerald also issued estimates for UnitedHealth Group’s FY2026 earnings at $17.60 EPS.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter in the prior year, the business earned $7.15 EPS. The business’s revenue for the quarter was up 12.2% on a year-over-year basis.

A number of other analysts have also recently commented on the company. Deutsche Bank Aktiengesellschaft cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target on the stock. in a research report on Wednesday. Royal Bank Of Canada boosted their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday. Wells Fargo & Company boosted their price target on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Barclays boosted their price target on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Finally, KeyCorp upped their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. Eighteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Stock Down 1.0%

UNH stock opened at $341.46 on Friday. UnitedHealth Group has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The business’s 50 day moving average price is $343.51 and its two-hundred day moving average price is $329.40. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The company has a market capitalization of $309.25 billion, a price-to-earnings ratio of 17.82, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47.

Hedge Funds Weigh In On UnitedHealth Group

Several hedge funds and other institutional investors have recently modified their holdings of UNH. Atlantic Edge Private Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 8.9% in the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock valued at $160,000 after purchasing an additional 25 shares in the last quarter. HHM Wealth Advisors LLC increased its stake in UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after purchasing an additional 26 shares during the period. Brogan Financial Inc. increased its stake in UnitedHealth Group by 3.4% in the first quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock valued at $429,000 after purchasing an additional 27 shares during the period. West Wealth Group LLC increased its stake in UnitedHealth Group by 3.2% in the first quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock valued at $462,000 after purchasing an additional 27 shares during the period. Finally, North Capital Inc. increased its stake in UnitedHealth Group by 16.2% in the third quarter. North Capital Inc. now owns 194 shares of the healthcare conglomerate’s stock valued at $67,000 after purchasing an additional 27 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.